Associate Professor of Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Timothy E. Wilens, MD
|
|
Give Review
Timothy Wilens is an expert in the field of Psychiatry. He attended University of Michigan Medical School. He has 4 awards "America's Top Doctors", "Boston Magazine", "Boston Herald" and "Super Doctor". Timothy Wilens is also published. He has 101 publications published. The lastest publication: "A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.' Timothy E. Wilens, MD is registered with Medicare and accepts Medicare payments.
Publications
- A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
- Reliability and Validity of the Before-School Functioning Scale in Children With ADHD.
- Prescription medication misuse among opioid dependent patients seeking inpatient detoxification.
- College Students: Mental Health Problems and Treatment Considerations.
- Parental history of substance use Disorders (SUD) and SUD in offspring: A controlled family study of bipolar Disorder.
- The complicated relationship between Attention deficit/hyperactivity disorder and substance use disorders.
- Does exposure to parental substance use Disorders increase substance use Disorder risk in offspring? A 5-year follow-up study.
- A cardiopulmonary study of lisdexamfetamine in adults with Attention-deficit/hyperactivity disorder.
- Difficulties in emotional regulation and substance use Disorders: A controlled family study of bipolar adolescents.
- Are obstetrical, perinatal, and infantile difficulties associated with pediatric bipolar Disorder?
- A controlled trial of extended-release guanfacine and psychostimulants for Attention-deficit/hyperactivity disorder.
- Correlates of alcohol use in adults with ADHD and comorbid alcohol use Disorders: exploratory analysis of a placebo-controlled trial of atomoxetine.
- Cardiovascular risk of stimulant treatment in pediatric Attention-deficit/hyperactivity disorder: update and clinical recommendations.
- Genome-wide association study of the child behavior checklist dysregulation profile.
- Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD.
- The intersection of Attention-deficit/hyperactivity disorder and substance abuse.
- Psychosocial functioning, familiality, and psychiatric comorbidity in Bipolar youth with and without psychotic features.
- Do executive function Deficits predict later substance use disorders among adolescents and young adults?
- Safety and efficacy of ABT-089 in pediatric Attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.
- A sobering fact: ADHD leads to substance abuse.
- Family-based genome-wide association scan of Attention-deficit/hyperactivity disorder.
- Understanding Attention-deficit/hyperactivity disorder from childhood to adulthood.
- A controlled trial of the methylphenidate transdermal system on before-school functioning in children with Attention-deficit/hyperactivity disorder.
- Adult psychiatric outcomes of girls with Attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study.
- Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.
- Presenting ADHD symptoms, subtypes, and comorbid Disorders in clinically referred adults with ADHD.
- Prescribing patterns for treatment of pediatric bipolar Disorder in a specialty clinic.
- An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics.
- An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness.
- Combined pharmacotherapy in pediatric psychopharmacology: friend or foe?
- Do stimulants protect against psychiatric Disorders in youth with ADHD? A 10-year follow-up study.
- A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar Disorder in children and adolescents.
- Does conduct Disorder mediate the development of substance use Disorders in adolescents with bipolar Disorder? A case-control family study.
- Concordance between cigarette smoking and the modified Fagerström Tolerance Questionnaire in controlled studies of ADHD.
- Effect of prior stimulant treatment for Attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolesc...
- Cigarette smoking associated with Attention deficit hyperactivity disorder.
- Varying the wear time of the methylphenidate transdermal system in children with Attention-deficit/hyperactivity disorder.
- Effects of methylphenidate on the catecholaminergic system in Attention-deficit/hyperactivity disorder.
- Stimulant therapy and risk for subsequent substance use Disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
- Pharmacotherapy of ADHD in adults.
- Supraventricular tachycardia in an adolescent with Attention-deficit/hyperactivity disorder (ADHD).
- Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
- Familial risk analyses of Attention deficit hyperactivity disorder and substance use disorders.
- When ADHD and substance use Disorders intersect: relationship and treatment implications.
- Does social class predict substance problems in young adults with ADHD?
- Impact of substance use Disorder on ADHD and its treatment.
- Association of bipolar and substance use Disorders in parents of adolescents with bipolar Disorder.
- Hematologic and blood biochemistry monitoring during methylphenidate treatment in children with Attention-deficit/hyperactivity disorder: 2-year, open-label study resu...
- ADHD: prevalence, diagnosis, and issues of comorbidity.
- Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD.
- Effect of stimulant medications for Attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
- The nature of the relationship between Attention-deficit/hyperactivity disorder and substance use.
- Substance use among ADHD adults: implications of late onset and subthreshold diagnoses.
- Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD.
- Attention deficit hyperactivity disorder and substance use disorders.
- Psychopathology in females with Attention-deficit/hyperactivity disorder: a controlled, five-year prospective study.
- Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
- Combination pharmacotherapy for adult ADHD.
- Stimulants and sudden death: what is a physician to do?
- Pharmacological management of a youth with ADHD, marijuana use, and mood symptoms.
- Effects of long-term atomoxetine treatment for young children with Attention-deficit/hyperactivity disorder.
- Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.
- Pharmacological management of a teen with significant alcohol use and depression.
- Long-term atomoxetine treatment in adolescents with Attention-deficit/hyperactivity disorder.
- A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar Disorder in children and adolescents.
- Alcohol, drugs, and Attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
- Once-daily OROS methylphenidate is safe and well tolerated in adolescents with Attention-deficit/hyperactivity disorder.
- ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of Attention-deficit/hyperactivity disorder in adults: results of a pilot study.
- An open-label study of the tolerability of mixed amphetamine salts in adults with Attention-deficit/hyperactivity disorder and treated primary essential hypertension.
- Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.
- Do children and adolescents with ADHD respond differently to atomoxetine?
- Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of Attention-deficit/hyperactivity disorder in adolescent patients: a 4...
- Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without Attention deficit hyperactivity disorder.
- Multisite controlled study of OROS methylphenidate in the treatment of adolescents with Attention-deficit/hyperactivity disorder.
- Mechanism of action of agents used in Attention-deficit/hyperactivity disorder.
- New developments in the treatment of ADHD.
- Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
- An open trial of adjunctive donepezil in Attention-deficit/hyperactivity disorder.
- Efficacy and tolerability of long-term, open-label, mixed amphetamine salts extended release in adolescents with ADHD.
- The need to study substance use Disorders.
- Pharmacotherapy of adolescent substance use Disorders: a review of the literature.
- The clinical dilemma of using medications in substance-abusing adolescents and adults with Attention-deficit/hyperactivity disorder: what does the literature tell us?
- Bupropion SR for the treatment of substance-abusing outpatient adolescents with Attention-deficit/hyperactivity disorder and mood disorders.
- Neuropsychological functioning in youth with bipolar Disorder.
- Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you?
- Short- and long-term cardiovascular effects of mixed amphetamine salts extended-release in adolescents with ADHD.
- Characteristics of adults with Attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
- Bupropion XL in adults with Attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
- Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study.
- Blood pressure changes associated with medication treatment of adults with Attention-deficit/hyperactivity disorder.
- Risk of substance use Disorders in adolescents with bipolar Disorder.
- Impact of executive function deficits and Attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children.
- A clinical perspective of Attention-deficit/hyperactivity disorder into adulthood.
- Attention-deficit/hyperactivity disorder in adults.
- Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
- Impact of ADHD and its treatment on substance abuse in adults.
- Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination.
- An open trial of bupropion for the treatment of adults with Attention-deficit/hyperactivity disorder and bipolar disorder.
- Can adults with Attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.
- Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar Disorder.
Schools
University of Mi Med Sch
Henry Ford Hospital
Mass Genl HospHarvard Med
Conditions Treated
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Major Depressive Disorder
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Boston Herald
- Super Doctor
Education
-
Massachusetts General Hospital -
Henry Ford Hospital - Wayne State University -
University of Michigan Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1295716074 | |
| NPPES Provider LastName | WILENS | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 215.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295716074 |
| Last Name Of The Provider | WILENS |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Reena Kapoor, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane I. Epstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael C. Arena, MD
This Doctor is OpenDoctor Recommended.
|